533 related articles for article (PubMed ID: 6100353)
1. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
2. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
5. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
7. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
[TBL] [Abstract][Full Text] [Related]
9. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
Hess G; Wagner J; Arnold W; Purcell RH; Meyer zum Büschenfelde KH
Z Immunitatsforsch Immunobiol; 1978 Jun; 154(3):208-17. PubMed ID: 676425
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
12. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
[TBL] [Abstract][Full Text] [Related]
13. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
15. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
16. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
Yap SF; Wong NW; Goh KL
Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
[TBL] [Abstract][Full Text] [Related]
19. [Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].
Dou YL; Cheng XQ; Li YZ; Han JH; Ni AP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):709-11. PubMed ID: 17172114
[TBL] [Abstract][Full Text] [Related]
20. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
